Probiotic Bifidobacterium animalis subsp. lactis DS109-B11 ameliorates age-related muscle weakness via AMPK activation
Open Access
- 12 April 2026
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
Sarcopenia, the age-related loss of skeletal muscle mass and function, represents a growing health burden with limited therapeutic options. Given the emerging roles of the gut–muscle axis and AMP-activated protein kinase (AMPK) in muscle homeostasis, we sought to identify gut-derived microbial strains that enhance muscle function via AMPK activation. We identified Bifidobacterium animalis subsp. lactis DS109-B11 as a potent AMPK activator. DS109-B11 microbial culture supernatant (MCS) increased AMPK phosphorylation during C2C12 myoblast differentiation, enhanced myogenic differentiation, and mitigated dexamethasone-induced myotube atrophy in vitro. In aged mice, oral administration of live DS109-B11 improved grip strength and motor performance and increased myofiber cross-sectional area, accompanied by elevated AMPK phosphorylation, upregulated mitochondrial and oxidative phosphorylation genes, and downregulated atrophy- and inflammation-related genes in skeletal muscle. In a botulinum toxin–induced neurogenic atrophy model, DS109-B11 treatment partially preserved tibialis anterior muscle mass, improved myofiber cross-sectional area, and suppressed atrophy-related gene expression. These findings identify DS109-B11 as an AMPK-activating probiotic strain that beneficially modulates skeletal muscle differentiation, enhances resilience to catabolic stress, and improves muscle function in vivo.Keywords
Funding Information
- Korea Innovation Foundation (2021-DD-UP0380)
- National Research Council of Science and Technology (CRC22013-200)
- National Research Foundation of Korea (RS-2026-25496234)
- National Research Foundation of Korea (RS-2026-25474708)
- KRIBB Research Initiative Program
This publication has 53 references indexed in Scilit:
- ExermiR‐129‐3p Enhances Muscle Function by Improving Mitochondrial Activity Through PARP1 InhibitionJournal of Cachexia, Sarcopenia and Muscle, 2025
- Impact of ageing and disuse on neuromuscular junction and mitochondrial function and morphology: Current evidence and controversiesAgeing Research Reviews, 2024
- A subset of microRNAs in the Dlk1‐Dio3 cluster regulates age‐associated muscle atrophy by targeting Atrogin‐1Journal of Cachexia, Sarcopenia and Muscle, 2020
- Muscular Strength as a Predictor of All-Cause Mortality in an Apparently Healthy Population: A Systematic Review and Meta-Analysis of Data From Approximately 2 Million Men and WomenArchives of Physical Medicine and Rehabilitation, 2018
- Early molecular response and microanatomical changes in the masseter muscle and mandibular head after botulinum toxin intervention in adult miceAnnals of Anatomy - Anatomischer Anzeiger, 2018
- Welcome to the ICD‐10 code for sarcopeniaJournal of Cachexia, Sarcopenia and Muscle, 2016
- AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling networkAgeing Research Reviews, 2012
- PGC-1α Promotes Nitric Oxide Antioxidant Defenses and Inhibits FOXO Signaling Against Cardiac Cachexia in MiceThe American Journal of Pathology, 2011
- Autophagy Is Required to Maintain Muscle MassCell Metabolism, 2009
- The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophyBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2008